RTW INVESTMENTS, LP
85 holdingsFiling period: 2026-06-30Current AUM: $11.60Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.99M | $1.07B | $1.04B | 8.99% | -- | 2026-06-30 |
| 2 | ARGX | ARGENX SE | 709.4K | $658.2M | $695.1M | 5.99% | -- | 2026-06-30 |
| 3 | PTCT | PTC THERAPEUTICS INC | 7.75M | $631.9M | $508.6M | 4.38% | -- | 2026-06-30 |
| 4 | PTGX | PROTAGONIST THERAPEUTICS INC | 5.06M | $620.4M | $725.8M | 6.26% | +2.1K | 2026-06-30 |
| 5 | CGON | CG ONCOLOGY INC | 8.51M | $605.0M | $617.7M | 5.33% | +1.53M | 2026-06-30 |
| 6 | INSM | INSMED INC | 4.84M | $516.3M | $580.8M | 5.01% | -- | 2026-06-30 |
| 7 | TNGX | TANGO THERAPEUTICS INC | 13.90M | $434.5M | $332.1M | 2.86% | +600.0K | 2026-06-30 |
| 8 | SYRE | SPYRE THERAPEUTICS INC | 4.25M | $377.5M | $386.7M | 3.33% | +80.0K | 2026-06-30 |
| 9 | CELC | CELCUITY INC | 3.30M | $345.8M | $273.3M | 2.36% | +265.3K | 2026-06-30 |
| 10 | ERAS | ERASCA INC | 17.95M | $328.8M | $291.6M | 2.51% | +1.79M | 2026-06-30 |
| 11 | RDNT | RADNET INC | 4.85M | $298.9M | $373.8M | 3.22% | +562.0K | 2026-06-30 |
| 12 | ORKA | ORUKA THERAPEUTICS INC | 3.14M | $298.7M | $289.4M | 2.50% | +1.08M | 2026-06-30 |
| 13 | NTRA | NATERA INC | 1.00M | $271.4M | $350.8M | 3.02% | -250,000 | 2026-06-30 |
| 14 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 7.80M | $260.3M | $101.9M | 0.88% | +4.15M | 2026-06-30 |
| 15 | IRTC | IRHYTHM HOLDINGS INC | 2.18M | $259.6M | $244.2M | 2.11% | +514.1K | 2026-06-30 |
| 16 | CYTK | CYTOKINETICS INC | 2.86M | $243.8M | $198.4M | 1.71% | +140.8K | 2026-06-30 |
| 17 | KLRA | KAILERA THERAPEUTICS INC | 10.78M | $237.4M | $144.9M | 1.25% | -- | 2026-06-30 |
| 18 | — | ESTABLISHMENT LABS HLDGS INC | 2.66M | $227.9M | $227.9M | 1.96% | -- | 2026-06-30 |
| 19 | GH | GUARDANT HEALTH INC | 1.48M | $222.2M | $260.1M | 2.24% | -- | 2026-06-30 |
| 20 | NBIX | NEUROCRINE BIOSCIENCES INC | 1.27M | $213.7M | $190.2M | 1.64% | +205.9K | 2026-06-30 |
| 21 | TARS | TARSUS PHARMACEUTICALS INC | 3.36M | $211.3M | $262.6M | 2.26% | +11.0K | 2026-06-30 |
| 22 | STOK | STOKE THERAPEUTICS INC | 5.62M | $184.0M | $158.3M | 1.36% | -- | 2026-06-30 |
| 23 | — | UNIQURE NV | 3.94M | $181.5M | $181.5M | 1.57% | +1.36M | 2026-06-30 |
| 24 | ACAD | ACADIA PHARMACEUTICALS INC | 7.14M | $180.8M | $191.2M | 1.65% | -- | 2026-06-30 |
| 25 | RGEN | REPLIGEN CORP | 1.24M | $169.3M | $216.8M | 1.87% | +34.6K | 2026-06-30 |
← Scroll →
Page 1 of 4